PNW Headlines

PsychedelicNewsBreaks

PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances IP Portfolio With EPO Notice of Intent to Grant Patent
Silo Pharma Inc. (SILO)
April 7, 2026
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Labeling Feedback for Preservative-Free Ketamine Application
NRx Pharmaceuticals Inc.
April 6, 2026
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Guidance Supporting NDA Review For NRX-100
NRx Pharmaceuticals Inc. (NRXP)
March 16, 2026
PsychedelicNewsBreaks – Helus Pharma(TM) (NASDAQ: HELP) (Cboe CA: HELP) Appoints Jill Conwell as Chief People Officer
Helus Pharma (HELP)
March 12, 2026
PsychedelicNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Opens Palm Beach Clinic for Depression and PTSD Treatment
NRx Pharmaceuticals Inc. (NRXP)
March 9, 2026
View More PsychedelicNewsBreaks

PsychedelicNewsWire Articles

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Appoints TMS, Neuroplasticity Researcher Joshua Brown MD, PhD, as Chief Medical Innovation Officer
NRx Pharmaceuticals, Inc. (NRXP)
March 11, 2026
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Pursues Dual Pathway for Preservative-Free Ketamine-Based Therapies
NRx Pharmaceuticals, Inc. (NRXP)
October 16, 2025
Global Psychedelic Week 2025 to Unite 5,000 People Across 100 Countries
Global Psychedelic Week
October 14, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Gains FDA Nod for Preservative-Free Ketamine Suitability Petition
NRx Pharmaceuticals, Inc. (NRXP)
October 7, 2025
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-100 in Suicidal Depression
NRx Pharmaceuticals, Inc. (NRXP)
September 2, 2025
View All PsychedelicNewsWire Articles

Public Press Releases

Filter Releases
Filters
Sector



Remove All Filters
Symbol Release Time Source
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}} {{ release.source }}
Load More

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

PsychedelicNewsWire
PsychedelicNewsWire

1108 Lavaca St
Suite 110-PNW
Austin, TX 78701
(512) 354-7000

Copyright © . PsychedelicNewsWire / 1108 Lavaca St Suite 110-PNW Austin, TX 78701 (512) 354-7000 / Disclaimers